SEC Filing (8-K) - Current Report Filing
(WorldNews Japan)

ex_205104.htm Exhibit 99.1 GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split ATLANTA, GA, September24, 2020 - GeoVax Labs, Inc.(NasdaqCM: GOVX, GOVXW) (`GeoVax` or the `Company`), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the pricing of its underwritten public offering of 2,560,000 units at a price to the public of $5.00 per unit. Each unit issued in the offering consists of one share of common stock (or pre-funded warrant to purchase common stock in lieu thereof) and one warrant to purchase one share of common stock at an exercise price of $5.00. The...